Kristen Snyder, MD

female silhouette icon
Kristen Snyder, MD, is an attending physician with the Cancer Center and Associate Clinical Director of the Comprehensive Vascular Anomalies Program (CVAP) at Children's Hospital of Philadelphia.

Locations: Main Campus

Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Medical School

MD - Michigan State University College of Human Medicine, East Lansing, MI

Internship

Pediatrics - University of Michigan Department of Pediatrics Residency Program, C.S. Mott Children's Hospital, East Lansing, MI

Residency

Pediatrics - University of Michigan Department of Pediatrics Residency Program, C.S. Mott Children's Hospital, East Lansing, MI

Fellowship

Pediatric Hematology/Oncology - Johns Hopkins University/National Cancer Institute, Baltimore, MD

Board Certification

Pediatric Hematology/Oncology
Pediatrics

Titles and Academic Titles

Attending Physician

Departments and Services

Publications

Papers

2016

Howard Leigh M, Gilbert Leslie, Zwerner Jeffrey P, Snyder Kristen M, Di Pentima M Cecilia: Subcutaneous Colletotrichum truncatum Infection in a Child. The Pediatric Infectious Disease Journal 35(4): 455-7, Apr 2016.

Chinnadurai Sivakumar, Fonnesbeck Christopher, Snyder Kristen M, Sathe Nila A, Morad Anna, Likis Frances E, McPheeters Melissa L: Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis. Pediatrics 137(2): e20153896, Feb 2016

2014

Stevens Patrick L, Johnson Douglas B, Thompson Mary Ann, Keedy Vicki L, Frangoul Haydar A, Snyder Kristen M: Adult neuroblastoma complicated by increased intracranial pressure: a case report and review of the literature. Case Reports in Oncological Medicine 2014: 341980, 2014.

2013

Snyder Kristen M, Reaman Gregory, Avant Debbie, Pazdur Richard: The impact of the written request process on drug development in childhood cancer. Pediatric Blood & Cancer 60(4): 531-7, Apr 2013.

2010

Haque Saadiya A, Kallakury Bhaskar, Shad Aziza, Snyder Kristen: A 5-year old male with "leukemic form" of disseminated post-transplant lymphoproliferative disorder. Pediatric Reports 2(1): e6, Jun 2010.

2008

Kim Su Young, Dabb Alix A, Glenn Donald J, Snyder Kristen M, Chuck Meredith K, Loeb David M: Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatric Blood & Cancer 50(4): 779-83, Apr 2008.

2007

Zhang Hua, Snyder Kristen M, Suhoski Megan M, Maus Marcela V, Kapoor Veena, June Carl H, Mackall Crystal L: 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. Journal of Immunology  179(7): 4910-8, Oct 2007.

2002

Snyder Kristen M, Rubin Mark A, Shulkin Barry L, Hutchinson Raymond J, Wechsler Daniel S: Mediastinal seminoma in a patient with Wiskott-Aldrich syndrome. Journal of Pediatric Hematology/Oncology 24(8): 672-6, Nov 2002.

Schlatter Marc, Snyder Kristen, Freyer David: Successful nonoperative management of typhlitis in pediatric oncology patients. Journal of Pediatric Surgery 37(8): 1151-5, Aug 2002.

Books

Chapters

2013

Snyder KM, Donoghue M, Helms WS, Reaman G.: Development of Drugs for Pediatric Cancers. Pediatric Drug Development: Concepts and Applications. Mulbert AE, Murphy D, Dunne J, Mathis LL (eds.). John Wiley & Sons, Ltd, 2, 2013.

2009

Mackall C, Snyder K: Cancers of Childhood: Solid Tumors and Amputations; "The psychiatric and psychological dimensions of pediatric cancer symptom management." Quick reference for Pediatric Oncology Clinicians  Weiner LS, Pao M, Kazak M, Kupst AE, Patenaude AF, Charlottesville, VA (eds.). IPOS Press, 2009.

Posters and Presentations

Invited Lectures

2019

Snyder K. "Supportive Care for Patients with Vascular Anomalies and Associated Syndromes", American Society of Pediatric Hematology Oncology Webinar series. Mar, 2019.

2018

Snyder K. "Management of Vascular Anomalies", Research Seminar, Pediatric Hematology and Oncology, Children's Hospital of Philadelphia. Nov, 2018.

Snyder K. "Treatment of Hemangiomas and Other Vascular Anomalies", Vascular Anomalies Symposium, Helen DeVos Children's Hospital Vascular Anomalies Symposium. Oct, 2018.

Snyder K. "Capizzi Made Easy: What is Optimal Sequence of Erwinia Asparaginase in Capizzi Methotrexate?", Journal Club, Pediatric Hematology/Oncology Division, Helen DeVos Children's Hospital, Grand Rapids, Michigan. May, 2018.

2017

Snyder K. "Periocular Vascular Anomalies", Pediatric Ophthalmology Grand Rounds, Helen DeVos Children's Hospital, Grand Rapids Michigan. Dec, 2017.

Snyder K. " Klippel Trenaunay" American Society of Pediatric Hematology Vascular Anomalies Special Interest Group. Oct, 2017.

Awards and Honors

2018, Consultant of the Month, Spectrum Health Emergency Department Helen DeVos Children's Hospital
2013, 2014, Nashville's Best Doctor's
2011, Group Recognition Award as a member of the Division of Drug Oncology Products, Food and Drug Administration
2007-2009, Fellow/Awardee, Washington D.C. Clinical Research Training Consortium
2006, Fellows Award for Research Excellence, National Institutes of Health

Editorial and Academic Positions

Editorial Positions

2019-present, Special Issue Editor, Pediatric Blood and Cancer
2017-present, Ad hoc reviewer, Pediatric Blood and Cancer
2017-present, Ad hoc reviewer, International Journal of Paediatric Dentistry

Leadership and Memberships

Memberships in Professional Organizations

International

2018-present, International Society for the Study of Vascular Anomalies
2012-present, Children's Oncology Group

National

2018-present, Consortium of iNvestigators of Vascular AnomalieS (CaNVAS)
 - 2018-present, Inaugural Member
2011-present, Go4theGoal Foundation Scientific Advisory Board
 - 2011-present, Scientific Advisor
2006-present, American Society of Pediatric Hematology
 - 2019-2020, Vascular Anomalies Special Interest Group, Education Chair
 - 2016-2018, Vascular Anomalies Special Interest Group, Education Vice Chair
 - 2013-present, Vascular Anomalies Special Interest Group, Steering Committee
 - 2013-present, Vascular Anomalies Special Interest Group